Université Laval, the first French-speaking institution of higher education in America, the Faculty of Pharmacy of Université Laval and the Research Center of the CHU de Québec-Université Laval (Oncology axis) wish to recruit a tenure-track professor (assistant, associate or full professor) at the Faculty of Pharmacy of Université Laval in the fields of radiopharmacy, radiochemistry or radiobiology.
The successful candidate for this position will hold a career (tenure-track) professor position in the Faculty of Pharmacy under a 100% employment system. The candidate must already be leading or aim to develop an innovative and interdisciplinary research program focused on the development and use of radiopharmaceuticals for molecular imaging (e.g. PET) and/or theranostic applications. The proposed research program may be centered on the development of new radiopharmaceuticals, the search for new biological targets, the development of new applications of molecular imaging and/or radiopharmaceutical therapy, applied to various fields of application
including, among others, oncology, neuroscience, or metabolic and inflammatory disorders. The successful candidate will have to develop a successful research program on these themes, funded by recognized external organizations, and will be encouraged to apply to CFI equipment grant programs, and Canada Research Chairs and Fonds de recherche du Québec – Santé (FRQS) Research Fellows competitions according to the admissibility criteria in effect.
The successful candidate will join established research groups including the Université Laval Cancer Research Center (CRC). In the last decade, the CHU de Québec – Université Laval has established itself as a reference center at the provincial and national levels in theranostics. In recent years, our institution has benefited from significant investments, including a new cyclotron and a state-of-the-art radiopharmaceutical science laboratory, equipped both for the development of new radiopharmaceuticals and the production for clinical use complying to good manufacturing practices (GMP). Chemistry, cellular and molecular biology laboratories, animal facilities and a large set of preclinical and clinical imaging devices (including PET) are already in place. Therefore, the successful candidate will have access to state-of-the-art research infrastructure offering a wide range of innovation opportunities across the continuum of new applications in nuclear medicine, and will join an established and very active clinical team eager to maintain its national leadership in theranostics. It is therefore a unique and ideal environment for a candidate interested in the rapid translation of discoveries into care that directly benefits
Salary support and start-up funds are available.
The successful candidate will be responsible for supervising graduate students enrolled in master’s and doctoral programs in pharmaceutical sciences in addition to participating in teaching at all levels, notably by enhancing and expending notions and educational tools aiming at an initiation to radiopharmacy.
In addition, the successful candidate will contribute to the development of courses and internships for the Postgraduate Professional
Diploma in Pharmaceutical Care Specialized in Theranostics.
More details can be found hereBack